ATTBF - Abattis Bioceuticals Corp.

Other OTC - Other OTC Delayed Price. Currency in USD
0.49661
-0.00539 (-1.07370%)
At close: 3:56PM EST
Stock chart is not supported by your current browser
Previous Close0.50200
Open0.53340
Bid0.00000 x 0
Ask0.00000 x 0
Day's Range0.47720 - 0.53340
52 Week Range0.04710 - 0.74440
Volume1,109,752
Avg. Volume1,871,346
Market Cap87.756M
Beta4.49
PE Ratio (TTM)N/A
EPS (TTM)-0.02900
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Newsfile5 days ago

    Abattis Announces Presence at 2018 Lift Cannabis Expo and Provides Corporate Updates

    Vancouver, British Columbia--(Newsfile Corp. - January 12, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, along with Northern Vine Labs, it will be attending the Lift Cannabis Expo, Canada's largest and best-attended cannabis tradeshow, from January 12 to 14 at the Vancouver Convention Centre. This year's Lift Expo will feature nearly 200 exhibitors from across North America and will host talks by cannabis thought ...

  • GlobeNewswire7 days ago

    Abattis Enters Into Definitive Agreement to Acquire Green Tree Therapeutics

    VANCOUVER, British Columbia, Jan. 11, 2018-- Abattis Bioceuticals Corp. is pleased to announce that, further to its news releases dated December 22, 2017, it has entered into a definitive agreement to ...

  • Newsfile7 days ago

    Abattis Successfully Closes $6.9 Million Private Placement and Announces New $8 Million Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - January 10, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, further to its news release dated January 4, 2018, it has successfully closed its non-brokered private placement of units (each, a "Unit") for gross proceeds of $6.9 million (the "Private Placement"). "Abattis has once again oversubscribed its private placement," said Rob Abenante, President and CEO of Abattis. "The Company ...

  • GlobeNewswire9 days ago

    Abattis Announces LOI for Partnership with Alliance of Beverage Licensees

    VANCOUVER, British Columbia, Jan. 09, 2018-- Abattis Bioceuticals Corp. is pleased to announce it has signed a letter of intent with the Alliance of Beverage Licensees to establish an exclusive complementary ...

  • Newsfile13 days ago

    Abattis Successfully Closes $6.7 Million Private Placement and Announces New $6 Million Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - January 4, 2018) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, further to its news releases dated December 15 and December 19, 2017, it has completed the second and final tranche of its non-brokered private placement of units (each, a "Unit") for gross proceeds of $6.7 million (the "Private Placement"). "The Company continues to see overwhelming demand for its private ...

  • GlobeNewswire26 days ago

    Abattis Provides Company Update and Comments on LOI Regarding Green Tree Therapeutics

    VANCOUVER, British Columbia, Dec. 22, 2017-- Abattis Bioceuticals Corp. is pleased to provide a company update and further commentary on its previously announced proposed acquisition of GT Therapeutics ...

  • Newsfile27 days ago

    Abattis Announces Letter of Intent to Acquire Winston Resources

    Vancouver, British Columbia--(Newsfile Corp. - December 22, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, effective today, it has entered into a non-binding letter of intent (the "LOI") with Winston Resources Inc. ("Winston Resources"), a reporting issuer listed on the Canadian Securities Exchange, which outlines the general terms and conditions of a proposed transaction (the "Proposed Transaction") that will result in Abattis acquiring ...

  • Newsfile29 days ago

    Abattis Successfully Closes $4 Million of $6 Million Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - December 19, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that, further to its news release dated December 15, 2017, it has completed the first tranche of its non-brokered private placement of units (each, a "Unit") for gross proceeds of up to $6 million (the "Private Placement")."The Company is very pleased by overwhelming demand for our private placement" said Rob ...

  • GlobeNewswirelast month

    Abattis Announces Expansion of Northern Vine Dealer’s License

    VANCOUVER, British Columbia, Dec. 18, 2017-- Abattis Bioceuticals Corp. is pleased to announce that Health Canada has approved an amendment to the dealer’ s license held by Northern Vine Canada Inc.. Northern ...

  • Newsfilelast month

    Abattis Announces Private Placement for Proceeds of up to $6 Million

    Vancouver, British Columbia--(Newsfile Corp. - December 15, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce that it is undertaking a non-brokered private placement (the "Offering") gross proceeds to the Company of up to $6 million."After strong demand for our last capital raise, the Company is pleased to announce a second capital raise at a significant increase in valuation" stated Rob Abenante, President and CEO of ...

  • GlobeNewswirelast month

    Northern Vine Labs Expands Dealer’s License with Health Canada

    VICTORIA, B.C., Dec. 15, 2017-- Northern Vine Labs, a subsidiary of Emerald Health Therapeutics Inc. and Abattis Bioceuticals Corp., today announced that Health Canada has approved an amendment to the ...

  • ACCESSWIRElast month

    Extraction Technology Becoming a Critical Process in Legal Cannabinoid Sector

    VANCOUVER, BC / ACCESSWIRE / December 14, 2017 / Before new cannabinoid-infused products can hit the market, a key process is required between the greenhouse and the store's shelves-Cannabinoid extraction ...

  • Newsfilelast month

    Abattis Successfully Closes Private Placement

    Vancouver, British Columbia--(Newsfile Corp. - December 12, 2017) - Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) (the "Company" or "Abattis") is pleased to announce it has successfully closed the previously announced non-brokered private placement for gross proceeds of up to $4,000,000 (the "Private Placement")"We are pleased by the confidence strategic investors have shown by this capital raise. Abattis will continue to work on organically growing our portfolio and searching for only the best strategic ...

  • GlobeNewswirelast month

    Abattis Confirms Breakthrough Extraction Technology Capabilities

    VANCOUVER, British Columbia, Dec. 12, 2017-- Abattis Bioceuticals Corp. is pleased to announce the successful completion of experiments confirming column chromatography extraction technology.. The experiments ...

  • Marketwired2 months ago

    Northern Vine Labs Combines the Best of Abattis and Emerald Health -- CFN Media

    CFN Media Group , the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering the partnership between Abattis Bioceuticals Corp. and Emerald ...

  • Newsfile2 months ago

    Northern Vine Labs Combines the Best of Abattis and Emerald Health -- CFN Media

    Seattle, Washington--(Newsfile Corp. - November 22, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering the partnership between Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF) and Emerald Health Therapeutics Inc. (TSXV: EMH) (OTCQX: EMHTF)  to run Northern Vine Laboratories as a joint venture, which promises to take advantage of a growing market for lab testing and extract products.Canada's Testing MarketCanada's ...

  • GlobeNewswire2 months ago

    Abattis Announces Completion of Investment by Emerald Health Therapeutics in Northern Vine

    VANCOUVER, British Columbia, Nov. 21, 2017-- Abattis Bioceuticals Corp. is pleased to announce the closing of its previously announced agreement with Emerald Health Therapeutics Inc. pursuant to which ...

  • GlobeNewswire2 months ago

    Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine

    VICTORIA, British Columbia, Nov. 21, 2017-- Emerald Health Therapeutics Inc. announced today that it has completed its previously announced investment of $2.5 million into Northern Vine Canada Inc. to ...

  • Marketwired2 months ago

    CFN Media Exclusive CEO Interview: Abattis Validates Lab Strategy, Sets Stage for Rapid Growth

    CFN Media Group , the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive executive interview with Rob Abenante, CEO of Abattis Bioceuticals Corp. ...

  • Newsfile2 months ago

    CFN Media Exclusive CEO Interview: Abattis Validates Lab Strategy, Sets Stage for Rapid Growth

    Seattle, Washington--(Newsfile Corp. - November 6, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive executive interview with Rob Abenante, CEO of Abattis Bioceuticals Corp. (CSE: ATT) (OTCQB: ATTBF). In the interview, Mr. Abenante discusses the company's cannabis testing and product development strategy in light of the recently announced partnership with Emerald Health Therapeutics.CFN: Let's talk about the general lay of the land in the cannabis ...

  • GlobeNewswire3 months ago

    Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine

    VICTORIA, British Columbia, Oct. 26, 2017-- Emerald Health Therapeutics Inc. announced today that it has signed a definitive agreement with Northern Vine Canada Inc. and Abattis Bioceuticals Corp. to invest ...

  • Marketwired3 months ago

    Abattis Offers a Solution to Canada's Cannabis Pesticide Problem -- CFN Media

    CFN Media Group , the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Abattis Bioceuticals Corp. , whose wholly-owned subsidiary is ...

  • PR Newswire3 months ago

    For Early Success in Cannabis Look Outside the Box

    USA News Group -To capture big gains prior to wide adoption and legalization in the marijuana space may require thinking a little outside the box or perhaps outside your geographical comfort zone. Many top pot stocks are on the rise and up hundreds of percent as the cannabis market is booming. The first obvious move is to focus on Canadian companies.